Literature DB >> 7993001

Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers.

S A Maloney1, M L Pearson, M T Gordon, R Del Castillo, J F Boyle, W R Jarvis.   

Abstract

OBJECTIVE: To assess the efficacy of control measures in decreasing nosocomial transmission of multidrug-resistant tuberculosis.
DESIGN: Retrospective cohort study.
SETTING: A teaching hospital in New York City. POPULATION: 40 patients hospitalized with multidrug-resistant tuberculosis (case-patients) and health care workers receiving tuberculin skin testing.
INTERVENTIONS: Centers for Disease Control and Prevention (CDC) 1990 guidelines for preventing transmission of tuberculosis, including 1) prompt isolation and treatment of patients with tuberculosis; 2) rapid diagnostic techniques for processing Mycobacterium tuberculosis specimens; 3) negative-pressure isolation rooms; and 4) molded surgical masks for health care workers. MEASUREMENTS: Proportion of case-patients with nosocomially acquired tuberculosis and rate of tuberculin skin test conversion among health care workers before and after implementation of control measures.
RESULTS: The proportion of patients with multidrug-resistant strains of M. tuberculosis decreased after the interventions (10 of 70 [14%] compared with 30 of 95 [32%] patients before the intervention; relative risk [RR], 0.5; 95% CI, 0.2 to 0.9). Before onset of multidrug-resistant tuberculosis, case-patients in the intervention period were as likely to be hospitalized on high-risk wards containing patients with tuberculosis (4 of 10 compared with 17 of 30 patients; RR, 0.7; P = 0.5) but were less likely to be exposed to another case-patient with tuberculosis (1 of 10 compared with 20 of 30 patients; RR, 0.2; P = 0.003). Tuberculin skin test conversion rates for health care workers assigned to wards housing patients with tuberculosis were lower in the intervention period than in the preintervention period (4 of 78 [5%] compared with 15 of 90 [17%] conversions; P = 0.02), decreasing to levels observed for workers assigned to other wards (4 of 78 [5%] compared with 9 of 228 [4%] conversions; P = 0.7).
CONCLUSIONS: Implementing control measures reduced nosocomial transmission of multidrug-resistant strains to patients and health care workers.

Entities:  

Mesh:

Year:  1995        PMID: 7993001     DOI: 10.7326/0003-4819-122-2-199501150-00002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

1.  Neonatal exposure to active pulmonary tuberculosis in a health care professional.

Authors:  Mithu Sen; Daniel Gregson; James Lewis
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  Mantoux (tuberculosis) testing. Evaluation of guidelines for testing in Canadian institutions.

Authors:  R E Thomas
Journal:  Can Fam Physician       Date:  1997-05       Impact factor: 3.275

4.  Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.

Authors:  Lelia H Chaisson; Marguerite Roemer; David Cantu; Barbara Haller; Alexander J Millman; Adithya Cattamanchi; J Lucian Davis
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

5.  Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures.

Authors:  Iacopo Baussano; Massimiliano Bugiani; Aurelia Carosso; Dario Mairano; Anna Pia Barocelli; Marina Tagna; Vincenza Cascio; Pavilio Piccioni; Walter Arossa
Journal:  Occup Environ Med       Date:  2006-08-15       Impact factor: 4.402

6.  Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.

Authors:  Neel R Gandhi; Darren Weissman; Prashini Moodley; Melissa Ramathal; Inga Elson; Barry N Kreiswirth; Barun Mathema; Elena Shashkina; Richard Rothenberg; Anthony P Moll; Gerald Friedland; A Willem Sturm; N Sarita Shah
Journal:  J Infect Dis       Date:  2012-11-19       Impact factor: 5.226

Review 7.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

8.  Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital.

Authors:  Lelia H Chaisson; David Duong; Adithya Cattamanchi; Marguerite Roemer; Margaret A Handley; Dean Schillinger; Matthew Sur; Phong Pham; Mary Ann Lin; L Elizabeth Goldman; Judy Quan; Saida Perez; Michael Healy; Julie Higashi; Lisa Winston; Barbara Haller; Anne F Luetkemeyer; J Lucian Davis
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

9.  Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV setting.

Authors:  Jennifer R Zelnick; Andrew Gibbs; Marian Loveday; Nesri Padayatchi; Max R O'Donnell
Journal:  J Public Health Policy       Date:  2013-05-30       Impact factor: 2.222

10.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.